✦ LIBER ✦

Patient characteristics and treatments associated with a decline in upper-body function following breast cancer therapy

✍ Scribed by Timothy L Lash; Rebecca A Silliman

Book ID: 117598545
Publisher: Elsevier Science
Year: 2000
Tongue: English
Weight: 66 KB
Volume: 53
Category: Article
ISSN: 0895-4356
DOI: 10.1016/s0895-4356(99)00176-6

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Risk factors for a decline in upper body

Risk factors for a decline in upper body function following treatment for early stage breast cancer

✍ Rebecca A. Silliman; Marianne N. Prout; Terry Field; Susan C. Kalish; Theodore C 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 32 KB

Risk of decline in upper-body function a

Risk of decline in upper-body function and symptoms among older breast cancer patients

✍ Jennifer L. Westrup; Timothy L. Lash; Soe Soe Thwin; Rebecca A. Silliman 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 104 KB

Risk of Decline in Upper-Body Function a

Risk of Decline in Upper-Body Function and Symptoms Among Older Breast Cancer Patients

📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 28 KB

Upper Body Pain and Functional Disorders

Upper Body Pain and Functional Disorders in Patients With Breast Cancer

✍ Stubblefield, Michael D.; Keole, Nandita 📂 Article 📅 2013 🏛 Wiley (John Wiley & Sons) 🌐 English ⚖ 784 KB

Modifiable patient factors are associate

Modifiable patient factors are associated with the late decline in renal function following liver transplantation

✍ Joanna A. Leithead; James W. Ferguson; Peter C. Hayes 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 114 KB

Patient and tumor characteristics associ

Patient and tumor characteristics associated with increased mortality in young women (≤40 years) with breast cancer

✍ Ankit Bharat; Rebecca L. Aft; Feng Gao; Julie A. Margenthaler 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 72 KB

## Abstract ## Background The goal of the current study is to identify predictors responsible for mortality disparities between young (≤40 years) and older (>40 years) women with breast cancer. ## Methods From 1998 to 2006, 344 patients ≤40 years were treated for breast cancer. Cox regression mo